PATENT CLAIM ANALYSIS

Application Number: 15898730
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "220000"]

Abstract:
The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.

Claim (Index 10):
The method of  claim 5 , wherein said neuroprotective agent is selegeline or riluzole.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 88.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12562621', '15388960', '15627145', '15017480', '15338214']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7781378143960268
- 35 USC 102 Novelty (BERT): 0.5261682193011298
- Combined Prediction Score: 0.7529408548865371
- Mean Citation Score: 255.78134
- Max Citation Score: 298.57587
- Similarity Product: 162.7404938686287

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test